Cargando…

Chemotherapy options in elderly and frail patients with metastatic colorectal cancer (MRC FOCUS2): an open-label, randomised factorial trial

BACKGROUND: Elderly and frail patients with cancer, although often treated with chemotherapy, are under-represented in clinical trials. We designed FOCUS2 to investigate reduced-dose chemotherapy options and to seek objective predictors of outcome in frail patients with advanced colorectal cancer. M...

Descripción completa

Detalles Bibliográficos
Autores principales:	Seymour, Matthew T, Thompson, Lindsay C, Wasan, Harpreet S, Middleton, Gary, Brewster, Alison E, Shepherd, Stephen F, O'Mahony, M Sinead, Maughan, Timothy S, Parmar, Mahesh, Langley, Ruth E
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lancet Publishing Group 2011
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3109515/ https://www.ncbi.nlm.nih.gov/pubmed/21570111 http://dx.doi.org/10.1016/S0140-6736(11)60399-1

Ejemplares similares

Oxaliplatin/capecitabine vs oxaliplatin/infusional 5-FU in advanced colorectal cancer: the MRC COIN trial
por: Madi, A, et al.
Publicado: (2012)

The value of evidence synthesis in randomised controlled trial (RCT) design, conduct and analysis: MRC clinical trials unit (CTU) at UCL experience
por: Tierney, Jayne F, et al.
Publicado: (2015)

Intermittent versus continuous oxaliplatin and fluoropyrimidine combination chemotherapy for first-line treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial
por: Adams, Richard A, et al.
Publicado: (2011)

MRC2020: improvements to Ximdisp and the MRC image-processing programs
por: Short, J. M., et al.
Publicado: (2023)

Toxicity associated with combination oxaliplatin plus fluoropyrimidine with or without cetuximab in the MRC COIN trial experience
por: Adams, R A, et al.
Publicado: (2009)

MRC2014: Extensions to the MRC format header for electron cryo-microscopy and tomography
por: Cheng, Anchi, et al.
Publicado: (2015)

Study of asymmetric $\phi$ factory options
por: Cline, David B, et al.
Publicado: (1994)

Chemotherapy options in elderly and frail patients with metastatic colorectal cancer
por: Saif, Muhammad Wasif
Publicado: (2012)

Historical Perspectives of the Role of the MRC
por: Williams, P. O.
Publicado: (1990)

Cohort differences in disease and disability in the young-old: findings from the MRC Cognitive Function and Ageing Study (MRC-CFAS)
por: Jagger, Carol, et al.
Publicado: (2007)

Synchrotron option for neutrino factory proton driver
por: Rees, G H, et al.
Publicado: (1999)

Issues in applying multi-arm multi-stage methodology to a clinical trial in prostate cancer: the MRC STAMPEDE trial
por: Sydes, Matthew R, et al.
Publicado: (2009)

Consumer involvement at the MRC Clinical Trials Unit: results of a survey
por: Vale, Claire L, et al.
Publicado: (2011)

Cardiovascular outcomes in patients with locally advanced and metastatic prostate cancer treated with luteinising-hormone-releasing-hormone agonists or transdermal oestrogen: the randomised, phase 2 MRC PATCH trial (PR09)
por: Langley, Ruth E, et al.
Publicado: (2013)

Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial
por: Sebag-Montefiore, David, et al.
Publicado: (2009)

Neoadjuvant cisplatin and fluorouracil versus epirubicin, cisplatin, and capecitabine followed by resection in patients with oesophageal adenocarcinoma (UK MRC OE05): an open-label, randomised phase 3 trial
por: Alderson, Derek, et al.
Publicado: (2017)

Capecitabine Versus Active Monitoring in Stable or Responding Metastatic Colorectal Cancer After 16 Weeks of First-Line Therapy: Results of the Randomized FOCUS4-N Trial
por: Adams, Richard A., et al.
Publicado: (2021)

Adjuvant therapy with oral sodium clodronate in locally advanced and metastatic prostate cancer: long-term overall survival results from the MRC PR04 and PR05 randomised controlled trials
por: Dearnaley, David P, et al.
Publicado: (2009)

The treatment of multiple myeloma--an important MRC trial.
por: Johnson, P. W., et al.
Publicado: (1994)

A feasibility study testing four hypotheses with phase II outcomes in advanced colorectal cancer (MRC FOCUS3): a model for randomised controlled trials in the era of personalised medicine?
por: Maughan, T S, et al.
Publicado: (2014)

Optional Front End Models for the Neutrino Factory Study II
por: Fukui, Y
Publicado: (2001)

Derived neutrophil lymphocyte ratio is predictive of survival from intermittent therapy in advanced colorectal cancer: a post hoc analysis of the MRC COIN study
por: Grenader, Tal, et al.
Publicado: (2016)

Prognostic value of pathological lymph node status and primary tumour regression grading following neoadjuvant chemotherapy – results from the MRC OE02 oesophageal cancer trial
por: Davarzani, Nasser, et al.
Publicado: (2018)

Prognostic Significance of Negative Lymph Node Long Axis in Esophageal Cancer: Results From the Randomized Controlled UK MRC OE02 Trial
por: Kloft, Maximilian, et al.
Publicado: (2023)

How frail is frail in oncology studies? A scoping review
por: Fletcher, James A., et al.
Publicado: (2023)

Effect of the plane of surgery achieved on local recurrence in patients with operable rectal cancer: a prospective study using data from the MRC CR07 and NCIC-CTG CO16 randomised clinical trial
por: Quirke, Phil, et al.
Publicado: (2009)

ExpMRC: explainability evaluation for machine reading comprehension
por: Cui, Yiming, et al.
Publicado: (2022)

Minimally invasive coronary artery bypass as an option for redo coronary surgery in a frail octogenarian
por: Kedziora, Anna, et al.
Publicado: (2021)

Attrition and bias in the MRC cognitive function and ageing study: an epidemiological investigation
por: Matthews, Fiona E, et al.
Publicado: (2004)

Medical statistics, patronage and the state: the development of the MRC Statistical Unit, 1911-1948.
por: Higgs, E
Publicado: (2000)

European principles of inhibitor management in patients with haemophilia: implications of new treatment options
por: Hermans, C., et al.
Publicado: (2020)

Addition of cetuximab to oxaliplatin-based first-line combination chemotherapy for treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial
por: Maughan, Timothy S, et al.
Publicado: (2011)

Biopsy proportion of tumour predicts pathological tumour response and benefit from chemotherapy in resectable oesophageal carcinoma: results from the UK MRC OE02 trial
por: Hale, Matthew D., et al.
Publicado: (2016)

Comparative Transcriptome Profiling of an SV40-Transformed Human Fibroblast (MRC5CVI) and Its Untransformed Counterpart (MRC-5) in Response to UVB Irradiation
por: Chang, Cheng-Wei, et al.
Publicado: (2013)

How frail is frail? A systematic scoping review and synthesis of high impact studies
por: Gordon, E. H., et al.
Publicado: (2021)

Morphology of paraspinal muscles in frail and non-frail older adults evaluated through FRAIL scale
por: Huang, Rufeng, et al.
Publicado: (2023)

Physical Activity in Non-Frail and Frail Older Adults
por: Jansen, F. Marijke, et al.
Publicado: (2015)

Current treatment options for aggressive non-Hodgkin lymphoma in elderly and frail patients: practical considerations for the hematologist
por: Schmittlutz, Katrin, et al.
Publicado: (2021)

Microscale oxygraphy reveals OXPHOS impairment in MRC mutant cells
por: Invernizzi, F., et al.
Publicado: (2012)

Hosts of low redshift southern radio galaxies from the MRC
por: Mahabal, A, et al.
Publicado: (1997)

Cannot write session to /tmp/vufind_sessions/sess_jappsjtqik49urri6vaakca9qk